Cargando…

Correction: Overview of the current use of levosimendan in France: a prospective observational cohort study

Detalles Bibliográficos
Autores principales:	Cholley, Bernard, Bojan, Mirela, Guillon, Benoit, Besnier, Emmanuel, Mattei, Mathieu, Levy, Bruno, Ouattara, Alexandre, Tafer, Nadir, Delmas, Clément, Tonon, David, Rozec, Bertrand, Fellahi, Jean-Luc, Lim, Pascal, Labaste, François, Roubille, François, Caruba, Thibaut, Mauriat, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539228/ https://www.ncbi.nlm.nih.gov/pubmed/37770809 http://dx.doi.org/10.1186/s13613-023-01193-y

Ejemplares similares

Overview of the current use of levosimendan in France: a prospective observational cohort study
por: Cholley, Bernard, et al.
Publicado: (2023)

Impact of the perioperative inotropic support in grown-up congenital heart patients undergoing cardiac surgery: a propensity score adjusted analysis
por: Mauriat, Philippe, et al.
Publicado: (2020)

Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper
por: Cholley, Bernard, et al.
Publicado: (2019)

Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study)
por: Caruba, Thibaut, et al.
Publicado: (2016)

Idiopathic Recurrent Pericarditis: Not Really So Idiopathic?
por: Roubille, François, et al.
Publicado: (2022)

High-frequency oscillatory ventilation and short-term outcome in neonates and infants undergoing cardiac surgery: a propensity score analysis
por: Bojan, Mirela, et al.
Publicado: (2011)

Data on nation-wide activity in intensive cardiac care units in France in 2014
por: Roubille, François, et al.
Publicado: (2017)

Cost Analysis of Aprotinin Reintroduction in French Cardiac Surgery Centres: A Real-World Data-Based Analysis
por: Colson, Pascal, et al.
Publicado: (2023)

Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety
por: Girardis, M., et al.
Publicado: (2022)

Admissions to intensive cardiac care units in France in 2014: A cross-sectional, nationwide population-based study
por: Mercier, Grégoire, et al.
Publicado: (2018)

Relationships between the COVID-19 lockdown, socioeconomic factors and acute coronary syndrome hospitalisations in France
por: Plat, Rodney, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on the burden of chronic heart failure patients in France
por: Berthelot, Emmanuelle, et al.
Publicado: (2021)

Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Correction to: Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018)

Incidence, management, and prognosis of post-ischaemic ventricular septal defect: Insights from a 12-year tertiary centre experience
por: Treille de Grandsaigne, Henri, et al.
Publicado: (2022)

Intra‐aortic balloon pump: is the technique really outdated?
por: Akodad, Mariama, et al.
Publicado: (2020)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Renal Effects of Levosimendan: A Consensus Report
por: Yilmaz, Mehmet B., et al.
Publicado: (2013)

Use of Extracorporeal Membrane Oxygenation in Pneumocystis Pneumonia of an Infant with AIDS
por: Cane, Grégoire, et al.
Publicado: (2020)

Population structure and antimicrobial susceptibility of Pseudomonas aeruginosa from animal infections in France
por: Haenni, Marisa, et al.
Publicado: (2015)

AnaConDa Device: Solution to Perform Cardiac Surgery Without Intravenous Anesthetic During the Corona Virus Disease 2019 Pandemic
por: Labaste, François, et al.
Publicado: (2021)

Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial
por: Ellouze, Omar, et al.
Publicado: (2021)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Levosimendan in Right Ventricular Dysfunction
por: Kapoor, Mukul C.
Publicado: (2023)

Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
por: Kundra, Tanveer Singh, et al.
Publicado: (2018)

A perioperative surgeon-controlled open-lung approach versus conventional protective ventilation with low positive end-expiratory pressure in cardiac surgery with cardiopulmonary bypass (PROVECS): study protocol for a randomized controlled trial
por: Lagier, David, et al.
Publicado: (2018)

The 50‐year‐old pulmonary artery catheter: the tale of a foretold death?
por: Leurent, Guillaume, et al.
Publicado: (2020)

Impact of global warming on weight in patients with heart failure during the 2019 heatwave in France
por: Roubille, François, et al.
Publicado: (2022)

Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
por: Herpain, Antoine, et al.
Publicado: (2019)

Myocardial efficiency during levosimendan infusion
por: Voipio-Pulkki, L-M, et al.
Publicado: (2002)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Levosimendan for Perioperative Cardioprotection: Myth or Reality?
por: Santillo, Elpidio, et al.
Publicado: (2018)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Role of inhaled levosimendan in peripartum cardiomyopathy
por: Kaur, Parminder, et al.
Publicado: (2022)

Forme sévère de COVID-19 pendant la première vague épidémique en France : rôle des facteurs sociaux et des traitements empiriques
por: Beaumont, A., et al.
Publicado: (2021)

A review of levosimendan in the treatment of heart failure
por: Kasikcioglu, Hulya Akhan, et al.
Publicado: (2006)

Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nfrcn21792fc52lm11bun0njkt